Laurus Labs Limited (LAURUSLABS) — share transfer | 14 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Laurus Labs received SEBI Regulation 74(5) certificates from its share transfer agent for Q1 FY2026.
💡 Investor Takeaway
These certificates confirm regulatory compliance for shareholding records during the quarter, with no operational or financial impact disclosed.

Laurus Labs received share transfer agent certificates from KFin Technologies for the quarter ended June 30, 2026, confirming compliance with SEBI's Regulation 74(5) for dematerialized and rematerialized securities across listed exchanges.

📄 View Original Announcement (PDF)

About Laurus Labs Limited (LAURUSLABS)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,03,025.6 Cr P/E: 94.1 ROE: 20.6% ROCE: 20.8% Div Yield: 0.06%

View full LAURUSLABS stock details →

📡 Get AI alerts when LAURUSLABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LAURUSLABS — Free

📊 More LAURUSLABS filings

See all LAURUSLABS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LAURUSLABS files new disclosures

Track LAURUSLABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LAURUSLABS — Free

Free account · 2 AI queries/day